(AMS) American Shared Hospital - Ratings and Ratios
Gamma Knife, Proton Therapy, Radiation Therapy
AMS EPS (Earnings per Share)
AMS Revenue
Description: AMS American Shared Hospital
American Shared Hospital Services is a healthcare technology company that specializes in providing stereotactic radiosurgery and advanced radiation therapy solutions. The companys primary focus is on leasing Gamma Knife systems and proton beam radiation therapy equipment to cancer treatment centers, health systems, and cancer networks worldwide. With a strong presence in the global healthcare market, American Shared Hospital Services has established itself as a key player in the radiation therapy industry.
The companys business model is diversified across two main segments: Leasing and Retail. Through its Leasing segment, American Shared Hospital Services generates revenue by leasing its Gamma Knife systems and proton beam radiation therapy equipment to healthcare providers. The company also provides a range of support services, including planning, installation, reimbursement, and marketing support, to its clients. In its Retail segment, the company operates two single-unit Gamma Knife facilities, providing radiosurgery services directly to patients.
By analyzing the companys
Based on the analysis of
To make informed investment decisions, its essential to closely monitor the companys financial performance, industry trends, and market sentiment. Investors should also keep a close eye on the companys ability to expand its leasing business, improve its profit margins, and enhance its overall financial health.
Additional Sources for AMS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
AMS Stock Overview
Market Cap in USD | 16m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 1984-09-07 |
AMS Stock Ratings
Growth Rating | 7.09 |
Fundamental | 9.70 |
Dividend Rating | 5.60 |
Rel. Strength | -18.1 |
Analysts | - |
Fair Price Momentum | 2.05 USD |
Fair Price DCF | - |
AMS Dividends
Currently no dividends paidAMS Growth Ratios
Growth Correlation 3m | -57.5% |
Growth Correlation 12m | -73.2% |
Growth Correlation 5y | 51.5% |
CAGR 5y | 3.87% |
CAGR/Max DD 5y | 0.08 |
Sharpe Ratio 12m | -1.27 |
Alpha | -29.61 |
Beta | 0.023 |
Volatility | 33.46% |
Current Volume | 3.9k |
Average Volume 20d | 5.3k |
Stop Loss | 2.3 (-5.3%) |
As of July 16, 2025, the stock is trading at USD 2.43 with a total of 3,906 shares traded.
Over the past week, the price has changed by -2.41%, over one month by +1.25%, over three months by -10.66% and over the past year by -25.23%.
Neither. Based on ValueRay´s Fundamental Analyses, American Shared Hospital is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 9.70 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AMS is around 2.05 USD . This means that AMS is currently overvalued and has a potential downside of -15.64%.
American Shared Hospital has no consensus analysts rating.
According to our own proprietary Forecast Model, AMS American Shared Hospital will be worth about 2.2 in July 2026. The stock is currently trading at 2.43. This means that the stock has a potential downside of -9.05%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 4.9 | 99.6% |
Analysts Target Price | - | - |
ValueRay Target Price | 2.2 | -9.1% |